Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study

Jari Tiihonen(University of Eastern Finland), Markku Lähteenvuo(University of Eastern Finland), Antti Tanskanen(University of Eastern Finland), Heidi Taipale(Niuvanniemi Hospital), Pia Vattulainen, Fabian Hoti, Juha Mehtälä

The Lancet Psychiatry

June 2, 2017

10.1016/s2215-0366(17)30134-7

Cited by 57

Related Papers

Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors

|World Psychiatry|2022|624

Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1– and Neuropilin Receptor-1–Dependent Mechanisms

|Circulation|2009|195

Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema

|Circulation|2011|181

Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder

|JAMA Psychiatry|2018|147

Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations

|Drugs|2021|147